iTeos Therapeutics (ITOS)
(Delayed Data from NSDQ)
$10.80 USD
+0.20 (1.89%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $10.81 +0.01 (0.09%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Earnings News For ITOS
-
iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
-
iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates
-
iTeos Reports Second Quarter 2023 Financial Results and Provides Business Updates
-
ITeos Therapeutics, Inc. (ITOS) Reports Q1 Loss, Misses Revenue Estimates
-
iTeos Reports First Quarter 2023 Financial Results and Provides Business Updates
-
ITeos Therapeutics, Inc. (ITOS) Q4 Earnings and Revenues Surpass Estimates
-
iTeos Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
-
ITeos Therapeutics, Inc. (ITOS) Lags Q3 Earnings and Revenue Estimates
-
iTeos Reports Third Quarter 2022 Financial Results and Provides Business Updates
-
ITeos Therapeutics, Inc. (ITOS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
-
ITeos Therapeutics, Inc. (ITOS) Q2 Earnings and Revenues Lag Estimates
-
ITeos Therapeutics, Inc. (ITOS) Surpasses Q1 Earnings and Revenue Estimates
-
ITeos Therapeutics, Inc. (ITOS) Tops Q4 Earnings and Revenue Estimates
-
ITeos Therapeutics, Inc. (ITOS) Lags Q3 Earnings and Revenue Estimates